News

Miriam Alinikoff Returns to Levine Lee LLP as Partner

Miriam Alinikoff Returns to Levine Lee LLP as Partner

Miriam Alinikoff Returns to Levine Lee LLP

Levine Lee LLP, a premier litigation boutique recognized for handling high-stakes white collar, securities litigation, and complex civil cases, is thrilled to announce the return of partner Miriam "Mimi" Alinikoff. Her return comes after five fruitful years at the U.S. Attorney's Office, where she developed a profound expertise in legal matters related to healthcare and regulatory enforcement.

Expertise in White Collar and Complex Civil Matters

Ms. Alinikoff has proven to be an adept litigator, representing various clients, including individuals, corporations, and board committees, in complex civil litigation and regulatory matters. During her tenure with the U.S. Attorney's Office, she directed multiple investigations into fraud, particularly focusing on significant government programs. Her deep understanding of the False Claims Act and other compliance laws equips her to tackle intricate legal challenges effectively.

Attorney Leadership Praise

Seth L. Levine, Co-Founding Partner at Levine Lee, praised Ms. Alinikoff's exceptional skills, stating, "Mimi is an outstanding litigator and strategic counselor. We are delighted to welcome her back to our team, both professionally and personally. Her extensive experience, particularly in recent years, will greatly benefit our clients and strengthen our firm’s capabilities."

Co-Founding Partner Kenneth E. Lee echoed this sentiment, remarking, "Mimi has played an essential role in our firm's triumphs since its inception. We are honored that she has chosen to return to Levine Lee after her public service years, where she demonstrated unwavering dedication to justice. Her skills will bolster our already strong team and amplify the exceptional service we offer to clients."

A Personal Journey Back to Levine Lee

Reflecting on her return, Ms. Alinikoff expressed her excitement, saying, "Rejoining my colleagues and friends at Levine Lee is a privilege. The firm's unwavering commitment to client success is unparalleled, and I am eager to contribute to the outstanding outcomes they are known for. Levine Lee is where I started my legal career, and the skills I acquired here have enabled my success across diverse public and private matters. This firm truly feels like a second home to me, and I am excited to serve my clients here once again."

Career Highlights and Accomplishments

Ms. Alinikoff's journey in law began at Levine Lee as their first Associate back in 2011. She went on to clerk for the Honorable Nina Gershon at the U.S. District Court for the Eastern District of New York from 2014 to 2016. After her clerkship, she returned to Levine Lee and became a Partner in 2018. Over her career, she has had the opportunity to represent high-profile clients such as the Special Committees of the Board of Xerox Corporation and was part of the legal team that secured an acquittal for Deutsche Bank trader Gavin Black in the notable LIBOR-fixing case. Additionally, she was instrumental in representing the bankruptcy trustee for Lehman Brothers Inc. and has worked on numerous healthcare-related legal matters.

About Levine Lee LLP

Levine Lee LLP stands out as one of the strongest litigation boutiques in the country, consistently handling significant and complex securities litigation and white-collar crime cases. The firm has garnered extensive recognition from various esteemed organizations, repeatedly honored by Law360 as a White-Collar Practice Group of the Year. Additionally, they have been named a leading firm by Chambers USA for their expertise in Securities Litigation and White Collar Crime.

With a commitment to excellence, Levine Lee LLP has cultivated a reputation for robust advocacy and has shaped the careers of its attorneys, earning them individual accolades from respected publications like Lawdragon and Benchmark Litigation.

Frequently Asked Questions

What prompted Miriam Alinikoff to return to Levine Lee LLP?

Miriam Alinikoff returned to Levine Lee LLP to reunite with her colleagues and continue her legal career in a firm that she considers her second home, bringing her valuable experience from the U.S. Attorney's Office.

What areas of law does Miriam Alinikoff specialize in?

Miriam Alinikoff specializes in white-collar litigation, complex civil matters, healthcare-related issues, and regulatory enforcement, particularly focusing on compliance with laws like the False Claims Act.

What recognition has Levine Lee LLP received?

Levine Lee LLP has been recognized as a White-Collar Practice Group of the Year by Law360 and has garnered accolades from Chambers USA, Benchmark Litigation, and The Legal 500 for their expert handling of complex litigation cases.

Who are some notable clients represented by Miriam Alinikoff?

Throughout her career, Miriam Alinikoff has represented the Special Committees of the Board of Xerox Corporation and was involved in the successful defense of Deutsche Bank trader Gavin Black during the LIBOR investigation.

What is the significance of Levine Lee LLP in the legal landscape?

Levine Lee LLP is known for its significant impact in securities litigation and white-collar crime, offering unparalleled legal services and achieving exceptional outcomes for its clients in high-stakes litigation.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

TORRAS Stands Tall with iPhone 18 Pro Cases

Updated Category News Views 191

TORRAS Shines in Magnetic Stand Case Evaluation In the whirlwind of smartphone accessories, where the battle lines are drawn between protection and functionality, TORRAS has emerged victorious with its magnetic stand cases for the iPhone 18 Pro and its beefier brother, the iPhone 18 Pro Max. Expert Consumers—a trusted name in product evaluations—has given TORRAS the...

Continue Reading
Bio-Thera's New Data: A Game Changer for NSCLC?

Updated Category News Views 214

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Continue Reading
Aluminum Design Fumble: Geometry Over Wall Thickness

Updated Category News Views 135

A Misstep in Aluminum Design Practices Well, here's a nugget of wisdom for the metal enthusiasts out there—stop beefing up aluminum components with thicker walls and focus on smart geometry. This isn't a drill, folks. Mark Coyle, a seasoned mind over at American Custom Metals, has been waving the flag for smarter aluminum design methods right from Rochester, NY, and...

Continue Reading
Lilly's Sofe-M Shakes Up Ovarian Cancer Treatment

Updated Category News Views 295

Ovarian Cancer Treatment Sees a New Challenger Alright, folks, Eli Lilly (NYSE:LLY) is stepping up with their latest findings in ovarian cancer treatment, and it's got plenty of people in a buzz. They've dropped new data for their investigational drug, Sofetabart mipitecan, or 'Sofe-M' for short, which targets this unrelenting disease with a punch that’s hard to ignore....

Continue Reading
Axon Body 5: A Leap Forward in AI for Public Safety

Updated Category News Views 270

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Continue Reading
DigitalXForce Booms with 514% Growth and Major Backing

Updated Category News Views 282

Massive Growth and Strategic Investment in DigitalXForce Now here’s a company that’s shaking things up—DigitalXForce. Right on the back of a staggering 514% growth, they’ve corralled a strategic investment from Arsenal Growth Equity. If you blink, you might miss just how fast they’re sprinting through the tech landscape. Institutional Support Backing the...

Continue Reading
Alaska's Insurance Maze: Coverage Over Cheap Policies

Updated Category News Views 92

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Continue Reading
Apalutamide Boosts Outlook for Prostate Cancer Treatment

Updated Category News Views 69

Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...

Continue Reading
Survivors Secure $800M Settlement with NY Archdiocese

Updated Category News Views 143

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 86

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading

Top 5 Most Recently Viewed Articles

Oral Semaglutide Curbs Heavy Drinking: CU Study Insights

Updated Category News Views 12

New Frontiers in Tackling Alcohol Use Disorder Diabetes meds aren't just boxing in sugar levels; they're taking swings at alcohol cravings, too. The University of Colorado Anschutz threw their hat in the ring with a study that put oral semaglutide—usually in the diabetes and weight loss circuit—to a different test. Turns out, it's packing a punch against heavy...

Continue Reading
Julie Van Kleeck Strengthens Leadership at Paragon Space

Updated Category News Views 121

Julie Van Kleeck Joins Paragon Space Development Corporation Board Paragon Space Development Corporation (Paragon) proudly announces the appointment of Julie Van Kleeck to its Board of Directors. With a remarkable background in the space technology sector, Julie is set to enhance Paragon's mission with her extensive market insights and solid operational experience. Rich...

Continue Reading
Exploring Advanced Techniques for Fracture Healing in Orthopaedics

Updated Category News Views 302

Micromotion Nailing for Enhanced Fracture Healing OrthoXel is thrilled to announce an important presentation by Dr. Hannah Dailey, Co-Founder and Chief Scientific Officer, focusing on the innovative technique of micromotion nailing aimed at accelerating fracture healing. This presentation will be highlighted at an esteemed meeting gathering leading experts in the field of...

Continue Reading
Resilient Job Market Gains Amid Signs of Slowing Growth Ahead

Updated Category News Views 191

Overview of Recent Labor Market Trends The US economy has shown unexpected strength, adding more jobs than anticipated recently, instilling fresh optimism regarding the labor market's near-term stability. With political changes on the horizon, the economy's performance under the new administration remains a topic of interest. Nonetheless, we can assert that the incoming...

Continue Reading
MD Hyperbaric Expands Presence in Key U.S. Markets

Updated Category News Views 6

Expanding the Oxygen Therapy Frontier When you're talking about healing that's both ancient and cutting-edge, hyperbaric oxygen therapy (HBOT) kind of steals the show. MD Hyperbaric, calling the shots since 2021, is breaking new ground in San Antonio, Las Vegas, and Rochester. Why This Matters HBOT isn't just another fancy healthcare fad. We're seeing a real push toward...

Continue Reading